- GeoVax & Vaxeal collaborate in immunotherapy – January 2018 - Ebola publication in Nature scientific journal – January 2018 - GeoVax & Carogen collaborate on hepatitis B vaccine – February 2018 - GeoVax awarded fast track for Lassa Fever – April 2018 - GeoVax awarded NIH grant for Zika – May 2018 - GeoVax & Emory collaborate on HPV program for head & neck cancer – July 2018 - David Dodd appointed as Chairman and CEO – August 2018 - GeoVax & PharmaJet collaborate on Zika needle free vaccine – August 2018 - GeoVax awarded $2.4 million from DoD for Lassa Fever Vaccine – September 2018 - Publication of HIV Vaccine Review – October 2018 - Presentation of Phase I trial for HVTN 114 (HIV) – October 2018 - Collaboration with Virometix on HPV – November 2018 - Collaboration with Leidos on peptide PD-1 checkpoint inhibitors – November 2018